Optimization of the Diagnostic Capacity of Traditional Biomarkers in Muscle Damage and Its Use in the Diagnosis of Dermatomyositis and Polymyositis.
EJIFCC
; 35(1): 4-9, 2024 Apr.
Article
em En
| MEDLINE
| ID: mdl-38706738
ABSTRACT
BACKGROUND-AIM:
Creatine kinase (CK) and aldolase are markers traditionally used in the study of muscle damage (MD). As CK determination is more specific to muscle damage, the demand for both determinations in routine laboratory tests would entail an extra cost.METHODS:
Retrospective observational study conducted between 2019-2020. CK and aldolase concentrations from 218 patients were studied.ROC curves were analyzed for CK and aldolase for muscle damage detection. Cut-off values were selected for both strategies. Specifity of CK and aldolase for dermatomyositis or polymyositis diagnosis in our population was studied using the McNemar's test.RESULTS:
The area under the ROC curve (AUC) for total CK was 0.716 (95%CI 0.651-0.775), for CK in males it was 0.703 (95%CI 0.592-0.799), and for CK in females was 0.719 (95%CI 0.636-0.793). For aldolase, AUC was 0.505 (95%CI 0.437-0.573). Optimized cut-off points for each determination were 112 U/L for CK in men, with a sensitivity of 73.9% (95%CI 51.6-89.8) and a specificity of 49.2% (95%CI 35.9-62.5); 88 U/L for CK in women, with a sensitivity of 75.0% (95%CI 57.8-87.9) and specificity of 50.5% (95%CI 40.4-60.6); and 5.6 U/L for aldolase, with a sensitivity of 61.0% (95%CI 53.2-68.8) and a specificity of 38.8% (95%CI 26.5-52.6).Regarding the individuals diagnosed with dermatomyositis or polymyositis, 66.7% and 44.4% of them were correctly classified as pathological by CK and aldolase results, respectively. McNemar's test did not reveal significant differences.CONCLUSION:
The determination of CK offers a better diagnostic performance of MD and, in addition, does not present significant differences regarding the determination of aldolase in cases of polymyositis and dermatomyositis. Therefore, the single determination of CK would be sufficient for MD screening.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
EJIFCC
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Espanha